Related Experiment Videos
7-ketocholesterol in human and adapted milk formulas
F Scopesi1, P Zunin, M Mazzella
1Department of Pediatrics, G. Gaslini' Institute, Genoa University, Genoa, Italy.
Clinical Nutrition (Edinburgh, Scotland)
|October 17, 2002
Summary
Infant formula contains significantly higher levels of cholesterol oxidation products (COPs) than human milk. These potentially harmful compounds, like 7-ketocholesterol, are linked to adverse health effects.
Area of Science:
- Biochemistry
- Food Science
- Pediatric Nutrition
Background:
- Cholesterol oxidation products (COPs) are known to be cytotoxic and atherogenic.
- Limited data exists on COP intake in newborns via human milk or infant formula.
- Understanding COP levels in infant nutrition is crucial for infant health.
Purpose of the Study:
- To investigate cholesterol oxidation in adapted formula versus human milk.
- To compare the concentration of 7-ketocholesterol, a key COP biomarker, in both milk types.
Main Methods:
- Analysis of total 7-ketocholesterol in 10 human milk and 10 formula samples.
- Utilized high-performance liquid chromatography with diode array detection.
- Quantified 7-ketocholesterol in extracted lipids.
Main Results:
- 7-ketocholesterol levels in adapted formula were significantly higher than in human milk (P<0.05).
- Human milk 7-ketocholesterol levels were often below the limit of quantification (0.5 μg/g lipids).
- Adapted formula samples frequently exceeded this quantification limit (mean 3.6±4.0 μg/g lipids).
Conclusions:
- This study provides the first data on cholesterol oxide concentrations in human and formula milk.
- Manufacturing processes and nutrient sources significantly influence COP development in infant formula.
- Further surveillance is needed to prevent the formation of potentially toxic compounds in infant nutrition.